A new University of Washington Medicine study suggests psilocybin-assisted psychotherapy can reduce burnout and symptoms of ...
In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...
It was approved by the FDA in 2008 to treat major depressive disorder, and it was recently approved for teens.
People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...
Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...
Professionals with GRAND Mental Health are working to help people overcome depression by using the drug ketamine.
Depression affects millions of Americans every year, and the challenges can feel even more overwhelming during the holiday ...
Many individuals have been told that their illness is "treatment resistant." However, this only means that they haven't ...
Focusing treatments for depression and anxiety to gut cells instead of brain cells may help people feel better without side effects.
Relmada halted Phase 3 trials of NMDA receptor blocker for depression but will continue its early psilocybin program while ...
Research reveals new connections between the gut and brain, suggesting more targeted depression and anxiety treatments, and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results